Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Psychiatr Res. 2021 Feb 2;136:95–102. doi: 10.1016/j.jpsychires.2021.01.052

Table 1.

Study population characteristics

Coded SI N(%) Potential SI N (%) Total N(%)
Gender Female 125 (63%) 245 (61%) 370 (62%)
Male 75 (38%) 155 (39%) 230 (36%)
Ethnicity Hispanic or Latino or Spanish Origin 41 (21%) 75 (19%) 116 (19%)
Not Hispanic or Latino or Spanish Origin 93 (47%) 188 (47%) 281 (47%)
Unknown 75 (38%) 137 (34%) 212 (35%)
Race Asian 2 (1%) 10 (3%) 12 (2%)
Black or African American 20 (10%) 50 (13%) 70 (12%)
Native Hawaiian or Pacific Islander 0 (0%) 1 (<1%) 1 (<1%)
Other Combinations Not Described 38 (19%) 74 (19%) 112 (19%)
White 94 (47%) 172 (43%) 266 (44%)
Unknown 45 (23%) 93 (23%) 138 (23%)
Age* <20 9 (5%) 28 (7%) 37 (6%)
20-40 49 (25%) 95 (24%) 144 (24%)
40-60 73 (37%) 136 (34%) 209 (35%)
60-80 47 (24%) 112 (28%) 159 (27%)
80 + 22 (11%) 29 (7%) 51 (9%)
Encounters Hospital encounter 192 (96%) 296 (74%) 488 (81%)
Psychiatric hospital encounter 72 (36%) 39 (10%) 111 (19%)
Office visit 192 (96%) 377 (94%) 569 (95%)
Psychiatric Office visit 24 (12%) 129 (33%) 153 (26%)
Comorbidities** Depression 159 (80%) 237 (59%) 396 (66%)
Anxiety 76 (38%) 157 (39%) 233 (39%)
Hypertension 86 (43%) 134 (34%) 220 (37%)
Substance use disorder 85 (43%) 111 (28%) 196 (33%)
Diabetes 40 (20%) 69 (17%) 109 (18%)
HIV 15 (8%) 53 (13%) 68 (11%)
Total 200 400 600
*

Age at the time of first clinical note

**

5 most common comorbidities (ICD-10 diagnosis codes provided in Appendix A)